Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eelko Hak

Showing results (11-20 of 257) with videos related to

Pageof 26
Sort By:
Pharmacoepidemiology and Drug Safety|December 22, 2015
Estimating time-varying drug adherence using electronic records: extending the proportion of days covered (PDC) methodMaarten J Bijlsma, Fanny Janssen, Eelko Hak
Vaccine|January 30, 2013
Association of infant pneumococcal vaccination with pneumococcal pneumonia among mothers: a nested case-control study using the GPRDEelko Hak, Kimberly M Shea, Susan S Jick
Vaccine|November 11, 2008
Determinants of non-compliance with herpes zoster vaccination in the community-dwelling elderlyWim Opstelten, Gerrit A van Essen, Eelko Hak
Influenza and Other Respiratory Viruses|April 7, 2018
The potential economic value of influenza vaccination for healthcare workers in The NetherlandsMarjan J Meijboom, Josien Riphagen-Dalhuisen, Eelko Hak
The Journal of Antimicrobial Chemotherapy|November 1, 2012
Effect of pravastatin and fosinopril on recurrent urinary tract infectionsKoen B Pouwels, Sipke T Visser, Eelko Hak
Annals of Internal Medicine|September 22, 2010
Barriers to herpes zoster vaccinationWim Opstelten, Gerrit A van Essen, Eelko Hak
Plos One|November 16, 2019
Pharmacy-based predictors of non-adherence, non-persistence and reinitiation of antihypertensive drugs among patients on oral diabetes drugs in the NetherlandsSofa D Alfian, Petra Denig, André Coelho, et al.
Epidemiology (Cambridge, Mass.)|April 10, 2014
ACE inhibitors and urinary tract infectionsKoen B Pouwels, Jens H J Bos, Eelko Hak
The New England Journal of Medicine|August 20, 2003
Pneumococcal vaccination in older adultsEelko Hak, Marc J M Bonten, Arno W Hoes
Plos One|May 6, 2016
Meta-Analysis on Randomized Controlled Trials of Vaccines with QS-21 or ISCOMATRIX Adjuvant: Safety and TolerabilityEmilia Bigaeva, Eva van Doorn, Heng Liu, et al.
Pageof 26

Showing results (11-20 of 257) with videos related to

Sort By:
Pageof 26
Pharmacoepidemiology and Drug Safety|December 22, 2015
Estimating time-varying drug adherence using electronic records: extending the proportion of days covered (PDC) methodMaarten J Bijlsma, Fanny Janssen, Eelko Hak
Vaccine|January 30, 2013
Association of infant pneumococcal vaccination with pneumococcal pneumonia among mothers: a nested case-control study using the GPRDEelko Hak, Kimberly M Shea, Susan S Jick
Vaccine|November 11, 2008
Determinants of non-compliance with herpes zoster vaccination in the community-dwelling elderlyWim Opstelten, Gerrit A van Essen, Eelko Hak
Influenza and Other Respiratory Viruses|April 7, 2018
The potential economic value of influenza vaccination for healthcare workers in The NetherlandsMarjan J Meijboom, Josien Riphagen-Dalhuisen, Eelko Hak
The Journal of Antimicrobial Chemotherapy|November 1, 2012
Effect of pravastatin and fosinopril on recurrent urinary tract infectionsKoen B Pouwels, Sipke T Visser, Eelko Hak
Annals of Internal Medicine|September 22, 2010
Barriers to herpes zoster vaccinationWim Opstelten, Gerrit A van Essen, Eelko Hak
Plos One|November 16, 2019
Pharmacy-based predictors of non-adherence, non-persistence and reinitiation of antihypertensive drugs among patients on oral diabetes drugs in the NetherlandsSofa D Alfian, Petra Denig, André Coelho, et al.
Epidemiology (Cambridge, Mass.)|April 10, 2014
ACE inhibitors and urinary tract infectionsKoen B Pouwels, Jens H J Bos, Eelko Hak
The New England Journal of Medicine|August 20, 2003
Pneumococcal vaccination in older adultsEelko Hak, Marc J M Bonten, Arno W Hoes
Plos One|May 6, 2016
Meta-Analysis on Randomized Controlled Trials of Vaccines with QS-21 or ISCOMATRIX Adjuvant: Safety and TolerabilityEmilia Bigaeva, Eva van Doorn, Heng Liu, et al.
Pageof 26